Skip to main content
logo
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
4.370
0.00 (0.00%)
At close: Apr 8, 2026, 4:00 PM EDT
4.313
-0.057 (-1.30%)
After-hours: Apr 8, 2026, 8:00 PM EDT

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Sep '22
Market Cap
4982042251133533
Market Cap Growth
192.36%-9.32%99.00%222.74%7.39%-25.53%
Enterprise Value
356.4162.271.58106.51-8.66-21.24
Last Close Price
4.372.753.194.022.472.30
PE Ratio
--1.96-2.59-2.31-3.09-4.60
PS Ratio
563.22231.26155.0579.00-3.03
PB Ratio
1.570.990.781.510.640.57
P/TBV Ratio
1.560.980.711.430.640.57
P/FCF Ratio
--2.15-3.10-2.98--4.10
P/OCF Ratio
--2.48-12.32-3.07--4.24
EV/Sales Ratio
403.1770.441.0974.27--1.97
EV/EBITDA Ratio
--0.56-0.02-2.671.002.99
EV/EBIT Ratio
--0.55-0.02-2.601.002.87
EV/FCF Ratio
--0.65-0.02-2.80-2.66
Debt / Equity Ratio
0.010.010.010.0300.00
Debt / EBITDA Ratio
-0.03-0.03-0.05-0.06--0.06
Debt / FCF Ratio
-0.03-0.03-0.06-0.07--0.06
Net Debt / Equity Ratio
-0.68-0.68-0.77-0.09-0.80-0.93
Net Debt / EBITDA Ratio
1.281.282.520.175.057.56
Net Debt / FCF Ratio
1.491.493.070.18-6.73
Asset Turnover
0.000.000.010.0200.35
Inventory Turnover
-----7.96
Quick Ratio
5.055.0512.450.6616.4313.83
Current Ratio
5.175.1712.681.0717.0714.38
Return on Equity (ROE)
-41.44%-41.44%-43.34%-71.65%-39.38%-25.21%
Return on Assets (ROA)
-37.07%-37.07%-40.34%-49.66%-29.86%-23.64%
Return on Invested Capital (ROIC)
-117.03%-117.03%-100.32%-86.41%-150.92%-314.71%
Return on Capital Employed (ROCE)
-40.47%-40.47%-44.87%-59.68%-31.55%-25.25%
Earnings Yield
-20.71%-50.91%-38.56%-43.28%-32.39%-21.74%
FCF Yield
-19.13%-46.58%-32.25%-33.53%0.00%-24.40%
Buyback Yield / Dilution
-14.57%-14.57%-140.72%-88.39%-0.06%-0.00%
Total Shareholder Return
-14.57%-14.57%-140.72%-88.39%-0.06%-0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q